Up-regulation of the DR5 Expression by Proteasome Inhibitor MG132 Augments TRAIL-Induced Apoptosis in Soft Tissue Sarcoma Cell Lines
Hee-Jeong Cheong, Kyu Sang Lee, In Sook Woo, Jong-Ho Won, Jae Ho Byun
Cancer Res Treat. 2011;43(2):124-130. Published online 2011 Jun 30 DOI: https://doi.org/10.4143/crt.2011.43.2.124
Citations to this article as recorded by 
TRAIL-induced apoptosis and proteasomal activity – Mechanisms, signalling and interplay
Chiara Boccellato, Markus Rehm
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2024; 1871(4): 119688. CrossRef
Advancing the Management of Skull Base Chondrosarcomas: A Systematic Review of Targeted Therapies
Edoardo Agosti, Marco Zeppieri, Sara Antonietti, Tamara Ius, Marco Maria Fontanella, Pier Paolo Panciani
Journal of Personalized Medicine.2024; 14(3): 261. CrossRef
Proteasome inhibitors as anticancer agents
Giorgia Gazzaroli, Andrea Angeli, Arianna Giacomini, Roberto Ronca
Expert Opinion on Therapeutic Patents.2023; 33(11): 775. CrossRef
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
Eun Byeol Jo, Young Sang Lee, Hyunjoo Lee, Jae Berm Park, Hyojun Park, Yoon-La Choi, Doopyo Hong, Sung Joo Kim
BMC Cancer.2019;[Epub] CrossRef
Disulfide bond-disrupting agents activate the tumor necrosis family-related apoptosis-inducing ligand/death receptor 5 pathway
Mengxiong Wang, Mary E. Law, Bradley J. Davis, Elham Yaaghubi, Amanda F. Ghilardi, Renan B. Ferreira, Chi-Wu Chiang, Olga A. Guryanova, Daniel Kopinke, Coy D. Heldermon, Ronald K. Castellano, Brian K. Law
Cell Death Discovery.2019;[Epub] CrossRef
The combination of TRAIL and MG-132 induces apoptosis in both TRAIL-sensitive and TRAIL-resistant human follicular lymphoma cells
Jemal Adem, Mine Eray, Jonna Eeva, Ulla Nuutinen, Jukka Pelkonen
Leukemia Research.2018; 66: 57. CrossRef
Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets
Elahe Nazeri, Mohammad Gouran Savadkoohi, Keivan Majidzadeh-A, Rezvan Esmaeili
Critical Reviews in Oncology/Hematology.2018; 131: 102. CrossRef
TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data
Zakareya Gamie, Konstantinos Kapriniotis, Dimitra Papanikolaou, Emma Haagensen, Ricardo Da Conceicao Ribeiro, Kenneth Dalgarno, Anja Krippner-Heidenreich, Craig Gerrand, Eleftherios Tsiridis, Kenneth Samora Rankin
Cancer Letters.2017; 409: 66. CrossRef
Activation of TRAIL‐DR5 pathway promotes sensorineural degeneration in the inner ear
Shyan‐Yuan Kao, Vitor Y.R. Soares, Arthur G. Kristiansen, Konstantina M. Stankovic
Aging Cell.2016; 15(2): 301. CrossRef
Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
Akira Maekawa, Kenichi Kohashi, Masaaki Kuda, Kunio Iura, Takeaki Ishii, Makoto Endo, Tetsuya Nakatsura, Yukihide Iwamoto, Yoshinao Oda
BMC Cancer.2016;[Epub] CrossRef
The Importance of Being Dead: Cell Death Mechanisms Assessment in Anti-Sarcoma Therapy
Santiago Rello-Varona, David Herrero-MartÃn, Laura Lagares-Tena, Roser López-Alemany, Núria Mulet-Margalef, Juan Huertas-MartÃnez, Silvia Garcia-Monclús, Xavier GarcÃa del Muro, Cristina Muñoz-Pinedo, Oscar MartÃnez Tirado
Frontiers in Oncology.2015;[Epub] CrossRef
Development of a Novel Class of Mitochondrial Ubiquinol–Cytochrome c Reductase Binding Protein (UQCRB) Modulators as Promising Antiangiogenic Leads
Hye Jin Jung, Misun Cho, Yonghyo Kim, Gyoonhee Han, Ho Jeong Kwon
Journal of Medicinal Chemistry.2014; 57(19): 7990. CrossRef
Mitochondrial UQCRB regulates VEGFR2 signaling in endothelial cells
Hye Jin Jung, Yonghyo Kim, Junghwa Chang, Sang Won Kang, Jeong Hun Kim, Ho Jeong Kwon
Journal of Molecular Medicine.2013; 91(9): 1117. CrossRef
Cell Death Pathways as Therapeutic Targets in Rhabdomyosarcoma
Simone Fulda
Sarcoma.2012; 2012: 1. CrossRef